Title: Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.
Journal: BMC emergency medicine 20090101
3466-80-6
258282-23-4
3466-82-8
383129-36-0
60232-85-1
70665-05-3
85178-37-6 | (S)-Methyl 5-thioxopyrrolidine-2-carboxylate | AA00GKUM | MFCD27999902
813424-73-6 | 5-chloro-6-(dimethylamino)pyridine-3-carboxylic acid | AA00GMWS | MFCD11042991
80945-74-0 | 2(3H)-Benzothiazolone,5-methoxy-,hydrazone(9CI) | AA00GQSI | MFCD17178539
933600-89-6 | (Z)-4-Bromo-1,1,1,3-tetrafluorobut-2-ene | AA00GREE | MFCD08460476
9012-09-3 | CELLULOSE TRIACETATE | AA00GRNT | MFCD00132680
91944-47-7 | Trifluoropyruvic aldehyde, 20% aqueous solution | AA00GRVC | MFCD03092983
927800-38-2 | 4-Bromo-8-fluoroquinoline | AA00GS3Y | MFCD07700231
888711-53-3 | Potassium 1-trifluoroboratomethylpyrrolidine | AA00GSD2 | MFCD10700161
868151-37-5 | 2-(Dimethylamino)-2-(4-fluorophenyl)acetic acid | AA00GSND | MFCD08445732
928-50-7 | 5-Chloro-1-pentene | AA00GST2 | MFCD00039389